Cyagen Biosciences vs Aragen Life Sciences

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/apac-cyagen/aragen

Category	Cyagen Biosciences	Aragen Life Sciences
Listed site	cro	cro
Summary	Cyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical research, with specialized expertise in humanized mice, gene therapy vectors, and disease-specific models across oncology, neurology, and metabolic disorders.	Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.
Services	Specialized & Large-Animal Models Preclinical In Vivo Studies Preclinical In Vitro Studies In Vivo Efficacy Models Translational Research Discovery Research	Discovery Research Target Identification & Validation High-Throughput Screening Medicinal Chemistry Computational & In-Silico Drug Discovery Protein Engineering In Vitro Pharmacology In Vitro ADME / DMPK Safety Pharmacology Genetic Toxicology Preclinical In Vitro Studies Preclinical In Vivo Studies In Vivo Efficacy Models In Vivo PK / PD Studies GLP Toxicology Carcinogenicity Studies DART (Reproductive & Developmental Toxicology) Specialized & Large-Animal Models Bioanalysis LC-MS Bioanalysis (Small Molecule) Ligand-Binding Bioanalysis (Large Molecule) Immunogenicity Assays (ADA / NAb) Biomarker Assays Flow Cytometry Services Analytical Method Development & Validation ICH Stability Studies Translational Research US FDA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy Regulatory Affairs
Modalities	Biologics (Monoclonal Antibodies) Oligonucleotide Cell Therapy Gene Therapy AAV / Viral Vector Platform	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Antibody-Drug Conjugate (ADC) Oligonucleotide mRNA Cell Therapy Gene Therapy Peptide Vaccine
Indications	Oncology Immunology Neurology Metabolic Rare Disease Ophthalmology	Oncology Immunology Neurology Psychiatry Metabolic Cardiovascular Infectious Disease Rare Disease Respiratory Dermatology Ophthalmology Gastroenterology Nephrology Women's Health
Locations	Headquarters, Santa Clara, California, United States	Global Headquarters, Hyderabad, Telangana, India R&D and Manufacturing Campus, Hyderabad, Telangana, India R&D Campus, Hyderabad, Telangana, India Manufacturing Campus, Visakhapatnam, Andhra Pradesh, India R&D Campus, Bengaluru, Karnataka, India Biosafety Solutions, Pune, Maharashtra, India Regional Office, New Delhi, Delhi, India Sales Office, Tokyo, Japan Sales Office, Seoul, South Korea Sales Office, Cambridge, Massachusetts, USA R&D Campus, Morgan Hill, California, USA Sales Office, Utrecht, Netherlands Sales Office, Milan, Italy Sales Office, South Korea Global Headquarters & R&D and Manufacturing Campus, Hyderabad, Telangana, India R&D Campus, Pune, Maharashtra, India R&D Campus, New Delhi, Delhi, India Sales Office, New Jersey, New Jersey, USA Global Headquarters, R&D and Manufacturing Campus, Hyderabad, Telangana, India R&D Campus, Mallapur, Hyderabad, India
Certifications	AAALAC · Identifier: AAALAC-accredited facilities	USFDA · Identifier: EIR for Nacharam Unit 1
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.